共 25 条
- [11] Treatment rates and factors associated with direct-acting antiviral therapy for insured patients with hepatitis C-related hepatocellular carcinoma - A real-world nationwide studyALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (03) : 350 - 360Kam, Leslie Y.Yeo, Yee HuiJi, FanpuHenry, LindaCheung, RamseyNguyen, Mindie H.
- [12] Predictive models for hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C and sustained virological response (SVR) achieved with direct acting anti-viral (DAA) included in the ANRS CO22 hepather cohortJOURNAL OF HEPATOLOGY, 2020, 73 : S106 - S106Ganne-Carrie, NathalieJessica, AzziCeline, DorivalCagnot, CaroleFontaine, HeleneLusivka-Nzinga, ClovisPol, StanislasCarrat, Fabrice
- [13] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) IN PATIENTS WITH ADVANCED CHRONIC HEPATITIS C (CHC) TREATED WITH CURRENT DIRECT ACTING ANTIVIRAL(S) (DAA). HERACLIS: HELLENIC MULTICENTER REAL-LIFE COHORT STUDYGASTROENTEROLOGY, 2017, 152 (05) : S1093 - S1093Papatheodoridis, GeorgeManolakopoulos, SpiliosKapatais, AndreasSinakos, EmanuelElefsiniotis, IoannisGoulis, JohnDeutsch, MelanieVlachogiannakos, JohnDalekos, GeorgeKoskinas, JohnKaratapanis, StylianosSchina, MariaManesis, EmanuelKetikoglou, IoannisSevastianos, VassiliosTriantos, ChristosCholongitas, EvangelosPapageorgiou, Maria-VasilikiKourikou, AnastasiaKaraoulani, TheofanieEvangelidou, EftychiaKoukoufiki, ArgyroKaragiannakis, DimitriosGatselis, NikolaosTampaki, MariaNtetskas, GeorgiosTsolias, ChrisostomosVoulgaris, TheodorosIoannidou, PanagiotaAkriviadis, Evangelos
- [14] Direct-acting antivirals improve treatment outcomes in patients with chronic hepatitis C-related hepatocellular carcinoma treated with transarterial chemoembolization: a nationwide, multicenter, retrospective cohort studyJOURNAL OF HEPATOLOGY, 2020, 73 : S612 - S613Hyun, Hye KyungCho, Eun JuPark, Soo YoungHong, Young MiKim, Soon SunKim, Hwi YoungHeo, Nae-YunPark, Jung GilKim, Beom KyungPark, Jun YongKim, Do YoungAhn, Sang HoonHan, Kwang-HyubLee, JeonghoonYu, Su JongKim, Yoon JunYoon, Jung-HwanTak, Won YoungKweon, Young OhYoon, Ki TaeCho, MongCheong, Jae YounPark, Seung HaChon, Hye YeonChun, Ho SooLee, Jae SeungLee, HyeWonKim, Seung Up
- [15] Long-term outcome of patients with HCV-related, child's class a cirrhosis treated with interferon-alpha (IFN):: The impact of sustained virologic response (SVR) on hepatocellular carcinoma (HCC) occurence and mortalityHEPATOLOGY, 2005, 42 (04) : 229A - 230ABruno, SStroffolini, TGiacomo, AOSBollani, SBenvegnù, LGaeta, GBPersico, MMazzella, GAscione, AMangia, ASantantonio, TAndreone, PAlmasio, PL
- [16] LOW ANTIVIRAL TREATMENT RATE FOR PATIENTS WITH HEPATITIS C (HCV)-RELATED HEPATOCELLULAR CARCINOMA (HCC)-A REAL-WORLD NATIONWIDE U. S. STUDYHEPATOLOGY, 2023, 78 : S62 - S62Kam, Leslie YeemanYeo, Yee HuiJi, FanpuHenry, LindaCheung, RamseyNguyen, Mindie H.
- [17] Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort studyJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S502 - S502Papatheodoridis, G.Kapatais, A.Sinakos, E.Elefsiniotis, I.Goulis, J.Deutsch, M.Vlachogiannakos, J.Dalekos, G.Koskinas, J.Karatapanis, S.Schina, M.Manesis, E.Ketikoglou, I.Sevastianos, V.Triantos, C.Cholongitas, E.Papageorgiou, M. -V.Kourikou, A.Karaoulani, T.Evangelidou, E.Koukoufiki, A.Karagiannakis, D.Gatselis, N.Tampaki, M.Ntetskas, G.Tsolias, C.Voulgaris, T.Ioannidou, P.Akriviadis, E.Manolakopoulos, S.
- [18] FACTORS ASSOCIATED WITH LONG-TERM RISK OF LIVER-RELATED AND NON-LIVER-RELATED DEATH AFTER SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS C VIRUS TREATED WITH DIRECT-ACTING ANTIVIRALHEPATOLOGY, 2024, 80 : S1968 - S1969Tahata, YukiHikita, HayatoNozaki, YasutoshiIshida, HisashiHosui, AtsushiMiyazaki, MasanoriSakamori, RyotaroOhkawa, KazuyoshiTatsumi, NobuyukiNakanishi, FumihikoDoi, YoshinoriYakushijin, TakayukiSakakibara, MitsuruImanaka, KazuhoKakita, NaruyasuIio, SadaharuYoshida, YuichiDoi, AkiraYamada, RyokoKodama, TakahiroTatsumi, TomohideTakehara, Tetsuo
- [19] REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), AND/OR POST LIVER TRANSPLANT (PTX)VALUE IN HEALTH, 2020, 23 : S168 - S168Younossi, Z.Bacon, B.Curry, M.Flamm, S. L.Frick, A.Milligan, S.Radtchenko, J.Tsai, N.Afdhal, N.